LC
ABBV icon

Lawood & Co’s AbbVie ABBV Stock Holding History

Lawood & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.13M Sell
11,978
-25
-0.2% -$6.41K 2.17% 14
2026
Q2 		$3.02M Buy
12,003
+100
+0.8% +$21.5K 2.05% 13
2026
Q1 		$2.59M Sell
11,903
-652
-5% -$145K 2.4% 13
2025
Q4 		$2.87M Buy
+12,555
New +$2.86M 2.72% 10

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Lawood & Co's ABBV Position: Q3 2026 in Review

Lawood & Co reduced its AbbVie (ABBV) stake by 0.21% in Q3 2026, selling an estimated $6.41K and leaving 11,978 shares worth $3.13M. The position accounts for 2.17% of the portfolio, ranked #14.

Lawood & Co first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Lawood & Co held 11,978 shares of AbbVie worth $3.13M as of Q3 2026.
  • Lawood & Co sold 25 AbbVie shares in Q3 2026, an estimated $6.41K.
  • AbbVie made up 2.17% of Lawood & Co's portfolio in Q3 2026, its #14 holding.
  • Lawood & Co first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Lawood & Co's 13F filing for Q3 2026, filed 9 Oct 2026.